1. Home
  2. BCRX vs LMAT Comparison

BCRX vs LMAT Comparison

Compare BCRX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.26

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$97.68

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
LMAT
Founded
1986
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
BCRX
LMAT
Price
$8.26
$97.68
Analyst Decision
Strong Buy
Buy
Analyst Count
11
5
Target Price
$20.82
$105.80
AVG Volume (30 Days)
4.2M
223.4K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
381.40
30.57
EPS
N/A
0.68
Revenue
$25,186,000.00
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
$12.55
$8.88
P/E Ratio
N/A
$146.62
Revenue Growth
N/A
13.53
52 Week Low
$6.00
$79.01
52 Week High
$11.31
$118.01

Technical Indicators

Market Signals
Indicator
BCRX
LMAT
Relative Strength Index (RSI) 37.55 35.56
Support Level $7.94 $82.65
Resistance Level $8.68 $99.95
Average True Range (ATR) 0.46 4.66
MACD -0.08 -0.63
Stochastic Oscillator 23.34 11.95

Price Performance

Historical Comparison
BCRX
LMAT

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: